1. Home
  2. NLSP vs NEN Comparison

NLSP vs NEN Comparison

Compare NLSP & NEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • NEN
  • Stock Information
  • Founded
  • NLSP 2015
  • NEN 1977
  • Country
  • NLSP Switzerland
  • NEN United States
  • Employees
  • NLSP N/A
  • NEN N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • NEN Building operators
  • Sector
  • NLSP Health Care
  • NEN Real Estate
  • Exchange
  • NLSP Nasdaq
  • NEN Nasdaq
  • Market Cap
  • NLSP 5.2M
  • NEN 282.1M
  • IPO Year
  • NLSP 2021
  • NEN N/A
  • Fundamental
  • Price
  • NLSP $1.95
  • NEN $80.19
  • Analyst Decision
  • NLSP
  • NEN
  • Analyst Count
  • NLSP 0
  • NEN 0
  • Target Price
  • NLSP N/A
  • NEN N/A
  • AVG Volume (30 Days)
  • NLSP 532.9K
  • NEN 121.0
  • Earning Date
  • NLSP 12-31-2024
  • NEN 01-01-0001
  • Dividend Yield
  • NLSP N/A
  • NEN 1.99%
  • EPS Growth
  • NLSP N/A
  • NEN 67.91
  • EPS
  • NLSP N/A
  • NEN 3.91
  • Revenue
  • NLSP N/A
  • NEN $81,169,352.00
  • Revenue This Year
  • NLSP N/A
  • NEN N/A
  • Revenue Next Year
  • NLSP N/A
  • NEN N/A
  • P/E Ratio
  • NLSP N/A
  • NEN $20.63
  • Revenue Growth
  • NLSP N/A
  • NEN 10.81
  • 52 Week Low
  • NLSP $1.73
  • NEN $67.04
  • 52 Week High
  • NLSP $24.32
  • NEN $84.00
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 34.15
  • NEN 38.67
  • Support Level
  • NLSP $1.73
  • NEN $82.10
  • Resistance Level
  • NLSP $2.79
  • NEN $82.74
  • Average True Range (ATR)
  • NLSP 0.36
  • NEN 0.08
  • MACD
  • NLSP 0.04
  • NEN -0.29
  • Stochastic Oscillator
  • NLSP 14.67
  • NEN 0.00

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.

Share on Social Networks: